Command Palette

Search for a command to run...

SAROJA

45.85+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Financially Stressed

Saroja Pharma Industries India Ltd. shows no current financial metrics, indicating a lack of operational performance or reporting issues. In contrast, its peers demonstrate varying degrees of growth, profitability, and valuation metrics, highlighting Saroja as a financially weak company compared to the sector.

Key Points
  • Saroja Pharma has no reported financial performance metrics, making it difficult to assess its position against peers.
  • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories emerge as strong performers with significant revenue growth and profitability metrics.
  • Cipla Ltd. and Mankind Pharma Ltd. show solid growth and appealing valuation metrics, suggesting potential value picks within the sector.
Top Performers
Sun Pharmaceutical Industries Ltd.

Strong revenue growth (8.42% YoY) and solid profitability metrics (ROE of 16.13%, Profit Margin of 20.85%).

Dr. Reddy's Laboratories Ltd.

High ROE (21.76%) and solid growth trajectory (16.54% YoY revenue growth) with attractive valuation (PE of 15.50).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.